Involvement of the constituent chains of botulinum neurotoxins A and B in the blockade of neurotransmitter release.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMID 3197726)

Published in Eur J Biochem on November 15, 1988

Authors

E A Maisey1, J D Wadsworth, B Poulain, C C Shone, J Melling, P Gibbs, L Tauc, J O Dolly

Author Affiliations

1: Department of Biochemistry, Imperial College, London, England.

Articles by these authors

Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature (1992) 8.39

Inactivation properties of voltage-gated K+ channels altered by presence of beta-subunit. Nature (1994) 4.38

Anomalous rectification in the metacerebral giant cells and its consequences for synaptic transmission. J Physiol (1966) 3.18

In vitro correlate of immunity in a rabbit model of inhalational anthrax. Vaccine (2001) 3.03

Bacillus anthracis but not always anthrax. J Appl Bacteriol (1992) 2.72

Calcium influx in active Aplysia neurones detected by injected aequorin. Nat New Biol (1973) 2.63

Preparation of gram quantities of a purified R-factor-mediated penicillinase from Escherichia coli strain W3310. Biochem J (1972) 2.56

Loss of sensitivity to EDTA by Pseudomonas aeruginosa grown under conditions of Mg-limitation. J Gen Microbiol (1968) 2.47

Properties and production characteristics of vomiting, diarrheal, and necrotizing toxins of Bacillus cereus. Am J Clin Nutr (1979) 2.45

Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity. Infect Immun (1986) 2.16

Botulinum neurotoxin type C cleaves a single Lys-Ala bond within the carboxyl-terminal region of syntaxins. J Biol Chem (1995) 2.06

Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization. Nature (1984) 2.02

Identification of a novel enterotoxigenic activity associated with Bacillus cereus. J Clin Pathol (1976) 2.02

Treatment with unfunded drugs in oncology: the impact of access programmes and clinical trials. Intern Med J (2013) 2.01

Anthrax: the disease in relation to vaccines. Vaccine (1984) 1.99

Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci U S A (1999) 1.99

Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP/synaptobrevin. J Biol Chem (1993) 1.93

How botulinum and tetanus neurotoxins block neurotransmitter release. Biochimie (2000) 1.90

In vivo evidence that bacteria in urinary tract infection grow under iron-restricted conditions. Infect Immun (1985) 1.86

Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. I. Ultrastructural autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves. J Cell Biol (1986) 1.83

Acetylcholine receptor and ion conductance modulator sites at the murine neuromuscular junction: evidence from specific toxin reactions. Proc Natl Acad Sci U S A (1973) 1.82

The complete amino acid sequence of the Clostridium botulinum type A neurotoxin, deduced by nucleotide sequence analysis of the encoding gene. Eur J Biochem (1990) 1.78

Periodontitis: a risk factor for coronary heart disease? Ann Periodontol (1998) 1.77

Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release. Biochemistry (1996) 1.77

Role of divalent cations in the action of polymyxin B and EDTA on Pseudomonas aeruginosa. J Gen Microbiol (1969) 1.73

Central action of dendrotoxin: selective reduction of a transient K conductance in hippocampus and binding to localized acceptors. Proc Natl Acad Sci U S A (1986) 1.72

Heterosynaptic facilitation in neurones of the abdominal ganglion of Aplysia depilans. J Physiol (1965) 1.62

SNARE motif and neurotoxins. Nature (1994) 1.62

Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity. Med Microbiol Immunol (1988) 1.61

Characterization for enterotoxin production, virulence factors, and antibiotic susceptibility of Staphylococcus aureus isolates from various foods in Portugal. Food Microbiol (2009) 1.53

Comparison of liver transplantation outcomes from adult split liver and circulatory death donors. Br J Surg (2012) 1.49

Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H). Ann Oncol (2014) 1.44

Glial heterogeneity in expression of the inwardly rectifying K(+) channel, Kir4.1, in adult rat CNS. Glia (2000) 1.43

Monoclonal antibody-based immunoassay for type A Clostridium botulinum toxin is comparable to the mouse bioassay. Appl Environ Microbiol (1985) 1.43

Newer strategies for effective evaluation of primary melanoma and treatment of stage III and IV disease. J Am Acad Dermatol (2000) 1.43

Tetanus toxin and botulinum toxins type A and B inhibit glutamate, gamma-aminobutyric acid, aspartate, and met-enkephalin release from synaptosomes. Clues to the locus of action. J Biol Chem (1992) 1.43

Acetylcholine receptors: topographic distribution and pharmacological properties of two receptor types on a single molluscan neurone. J Physiol (1972) 1.42

Bacillus anthracis on Gruinard Island. Nature (1981) 1.41

Inactivation of Clostridium botulinum type A neurotoxin by trypsin and purification of two tryptic fragments. Proteolytic action near the COOH-terminus of the heavy subunit destroys toxin-binding activity. Eur J Biochem (1985) 1.41

Experimental anthrax vaccines: efficacy of adjuvants combined with protective antigen against an aerosol Bacillus anthracis spore challenge in guinea pigs. Vaccine (1995) 1.40

The relationship of angulation to translation in fracture deformities. J Bone Joint Surg Am (1994) 1.39

Treatment of anismus in intractable constipation with botulinum A toxin. Lancet (1988) 1.39

Development of novel assays for botulinum type A and B neurotoxins based on their endopeptidase activities. J Clin Microbiol (1996) 1.39

Tetanus toxin is a zinc protein and its inhibition of neurotransmitter release and protease activity depend on zinc. EMBO J (1992) 1.39

Mechanism of heterosynaptic facilitation in the giant cell of the abdominal ganglion of Aplysia depilans. J Physiol (1965) 1.38

Purification of anthrax-toxin components by high-performance anion-exchange, gel-filtration and hydrophobic-interaction chromatography. Biochem J (1988) 1.36

Multiple interneuronal afferents to the giant cells in Aplysia. J Physiol (1975) 1.35

Primary structure of a beta subunit of alpha-dendrotoxin-sensitive K+ channels from bovine brain. Proc Natl Acad Sci U S A (1994) 1.34

Preparation and characterisation of homogeneous neurotoxin type A from Clostridium botulinum. Its inhibitory action on neuronal release of acetylcholine in the absence and presence of beta-bungarotoxin. Eur J Biochem (1982) 1.34

Evaluation of a monoclonal antibody-based immunoassay for detecting type B Clostridium botulinum toxin produced in pure culture and an inoculated model cured meat system. J Appl Bacteriol (1988) 1.33

Transmission in invertebrate and vertebrate ganglia. Physiol Rev (1967) 1.32

Radiotherapy in the management of solitary extramedullary plasmacytoma. Intern Med J (2005) 1.31

Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series. Brain (2008) 1.30

Input organization of two symmetrical giant cells in the snail brain. J Physiol (1966) 1.29

Vesicle exocytosis stimulated by alpha-latrotoxin is mediated by latrophilin and requires both external and stored Ca2+. EMBO J (1998) 1.28

Subunit combinations defined for K+ channel Kv1 subtypes in synaptic membranes from bovine brain. Biochemistry (1997) 1.27

Differences in the protease activities of tetanus and botulinum B toxins revealed by the cleavage of vesicle-associated membrane protein and various sized fragments. Biochemistry (1994) 1.27

Protein kinase B stimulates the translocation of GLUT4 but not GLUT1 or transferrin receptors in 3T3-L1 adipocytes by a pathway involving SNAP-23, synaptobrevin-2, and/or cellubrevin. J Biol Chem (1999) 1.25

Radioiodination of botulinum neurotoxin type A with retention of biological activity and its binding to brain synaptosomes. Eur J Biochem (1983) 1.25

Binding of perhydro-histrionicotoxin to the postsynaptic membrane of skeletal muscle in relation to its blockage of acetylcholine-induced depolarization. Mol Pharmacol (1977) 1.24

The effects of purified botulinum neurotoxin type A on cholinergic, adrenergic and non-adrenergic, atropine-resistant autonomic neuromuscular transmission. Neuroscience (1982) 1.24

Tetanus and botulinum neurotoxins are zinc proteases specific for components of the neuroexocytosis apparatus. Ann N Y Acad Sci (1994) 1.23

Clostridium botulinum toxins: nature and preparation for clinical use. Eye (Lond) (1988) 1.23

Subunit composition of Kv1 channels in human CNS. J Neurochem (1999) 1.22

Studies on the oestrogen sulphatase and arylsulphatase C activities of rat liver. Biochem J (1972) 1.22

Antibodies specific for distinct Kv subunits unveil a heterooligomeric basis for subtypes of alpha-dendrotoxin-sensitive K+ channels in bovine brain. Biochemistry (1994) 1.20

A role for phospholipase D1 in neurotransmitter release. Proc Natl Acad Sci U S A (2001) 1.20

The New Poor Law and the County Pauper Lunatic Asylum--the Devon experience 1834-1884. Soc Hist Med (1996) 1.20

Botulinum neurotoxin and dendrotoxin as probes for studies on transmitter release. J Physiol (Paris) (1984) 1.19

Quantal release of acetylcholine examined by current fluctuation analysis at an identified neuro-neuronal synapse of Aplysia. Proc Natl Acad Sci U S A (1980) 1.18

Oligomeric properties of alpha-dendrotoxin-sensitive potassium ion channels purified from bovine brain. Biochemistry (1992) 1.18

Transmission abolished on a cholinergic synapse after injection of acetylcholinesterase into the presynaptic neurone. Nature (1974) 1.18

Botulinum neurotoxin type B. Its purification, radioiodination and interaction with rat-brain synaptosomal membranes. Eur J Biochem (1986) 1.17

Development of in vitro assays for the detection of botulinum toxins in foods. FEMS Immunol Med Microbiol (1999) 1.16

Non vesicular release of neurotransmitter. Physiol Rev (1982) 1.16

Hirschsprung's disease: a 20-year experience. J Pediatr Surg (1997) 1.15

Evaluation of a monoclonal antibody-based immunoassay for detecting type A Clostridium botulinum toxin produced in pure culture and an inoculated model cured meat system. J Appl Bacteriol (1987) 1.15

A study of various electrophoretic and inhibition techniques for separating serum alkaline phosphatase isoenzymes. Clin Chem (1972) 1.15

Multiple forms of dipeptidases in normal human intestinal mucosa and in mucosa from children with coeliac disease. Clin Chim Acta (1969) 1.15

Structural determinants of the specificity for synaptic vesicle-associated membrane protein/synaptobrevin of tetanus and botulinum type B and G neurotoxins. J Biol Chem (1996) 1.14

Decontamination of Bacillus anthracis on Gruinard Island? Nature (1983) 1.14

A 50-kDa fragment from the NH2-terminus of the heavy subunit of Clostridium botulinum type A neurotoxin forms channels in lipid vesicles. Eur J Biochem (1987) 1.12

Two acceptor sub-types for dendrotoxin in chick synaptic membranes distinguishable by beta-bungarotoxin. Eur J Biochem (1986) 1.12

Synapsin controls both reserve and releasable synaptic vesicle pools during neuronal activity and short-term plasticity in Aplysia. J Neurosci (2001) 1.12

Steady-state and pre-steady-state kinetics of coenzyme A linked aldehyde dehydrogenase from Escherichia coli. Biochemistry (1981) 1.12

Split liver transplantation: King's College Hospital experience. Ann Surg (1998) 1.12